Physician

Joshua Brian Dault, MD

According to 2025 Medicare claims, Joshua Dault, MD (NPI: 1154775724) practices radiation oncology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is NORTH FLORIDA CANCER CENTER TALLAHASSEE LLC (NPI: 1952398448; TIN: 522448724) and primary practice location at 32308-4893.

Dault's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 86 traditional Medicare patients, billed 2,297 HCPCS/CPT codes, and received $392,576 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 234 prescription claims across 82 beneficiaries totaling $66,034 in drug costs, led by Orgovyx (Relugolix). DME data shows 24 claims. Open Payments data shows 11 records totaling $347. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $937 to $66,034. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	16	125	$23,371
2022	82	1,216	$224,125
2023	98	1,771	$316,841
2024	86	2,297	$392,576

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	19	$937
2017	34	97	$3,697
2018	15	50	$1,366
2019	20	37	$973
2020	41	112	$2,555
2021	29	72	$1,640
2022	48	103	$1,732
2023	68	202	$55,914
2024	82	234	$66,034

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	24	$2,591

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	37	793	$262
77427	Radiation treatment management, 5 treatment sessions	36	163	$148
77014	Ct guidance for insertion of radiation therapy fields	38	798	$90
77336	Continuing radiation therapy consultation per week	42	170	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	32	50	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orgovyx	Relugolix	24	718	$63,077
Tamsulosin Hcl	Tamsulosin Hcl	124	8,046	$1,793
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	105	$92

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$2,182
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	12	$409

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$347	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joshua Brian Dault, MD?

Tedicare shows public-source Medicare data for Joshua Brian Dault, MD (NPI 1154775724), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Brian Dault, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua Brian Dault, MD?

Joshua Brian Dault, MD is linked to NORTH FLORIDA CANCER CENTER TALLAHASSEE LLC (billing NPI 1952398448) in the available physician profile data.

Does Joshua Brian Dault, MD have Open Payments data?

Joshua Brian Dault, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.